Joy Yan - 04 Nov 2024 Form 4 Insider Report for Moleculin Biotech, Inc. (MBRX)

Role
Director
Signature
/s/ Jonathan Foster by Power of Attorney
Issuer symbol
MBRX
Transactions as of
04 Nov 2024
Transactions value $
$0
Form type
4
Filing time
06 Nov 2024, 20:06:10 UTC
Previous filing
26 May 2023
Next filing
14 Nov 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MBRX Stock option (right to buy) Award +10,000 +2.5% 14,001 04 Nov 2024 Common Stock 10,000 $2.45 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options set forth in this table vest through April 2025, subject to the grantee's continued service on the Company's Board of Directors on each vesting date.
F2 The options were issued in connection with the reporting person's Board of Director service to the Company.